Search clinical trials for: Placebo (human albumin 1%)

Total 3848 results

Biogen

Completed

Single Ascending Dose Study of BIIB037 in Participants With Alzheimer's Disease

Alzheimer's Disease

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Not yet recruiting

A Study of Duvelisib Combined With SG001 Injection in Patient With Advanced Solid Tumors

Advanced Solid Tumors
Shanghai East Hospital

Recruiting

Effect of Mesenchymal Stem Cells(MSCs) Transplantation for Acute Cerebral Infarction Patients

Cerebral Infarction | Brain Infarction | Infarction, Middle Cerebral Artery | Stroke, Ischemic | Acute Stroke | Infarction, Anterior Cerebral Artery | Infarction, PCA | Infarction, Posterior Circulation, Brain

China
Esben Thyssen Vestergaard

Completed

Local Metabolic Effects of Ghrelin in Skeletal Muscle and Adipose Tissue

Healthy

Denmark
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II

Acute Myeloid Leukemia | Myelodysplastic Syndrome | Myeloproliferative Neoplasm | Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Cord Blood Transplant Recipient

United States
Third Affiliated Hospital, Sun Yat-Sen University

Unknown

RL-1 Novel Human-derived Bio-artificial Liver Treatment in Patients of HBV Related ACLF

Acute-On-Chronic Liver Failure | Hepatitis B

China
Medical University of Warsaw
Human Biome Institute, Poland

Not yet recruiting

The Impact of Fecal Microbiota Transplantation as an Immunomodulation on the Risk Reduction of COVID-19 Disease Progression With Escalating Cytokine Storm and Inflammatory Parameters (FeMToCOVID)

Covid19
Indonesia University
Ludwig-Maximilians - University of Munich

Completed

Indonesia After Discharge LBW Infant HMF Supplementation Study (DAHLIA)

Gestational Age and Weight Conditions | Breast Feeding, Exclusive | Low; Birthweight

Indonesia
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Stem Cell Network; Ontario Institute...

Unknown

Cellular Immunotherapy for Septic Shock (CISS2)

Pathologic Processes | Sepsis | Systemic Inflammatory Response Syndrome | Inflammation | Shock | Septic Shock | Infection
University of Miami
The Emmes Company, LLC

Completed

The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT) (TAC-HFT)

Stem Cell Transplantation | Ventricular Dysfunction, Left

United States
Bioniz Therapeutics
Celerion

Completed

A Multiple-Dose Study of Intravenous BNZ132-1-40 in Healthy Adult Subjects

Safety and Tolerability in Healthy Subjects

United States
MyMD Pharmaceuticals, Inc.

Completed

Evaluation of Efficacy, Tolerability, and Pharmacokinetics of MYMD1 for Chronic Inflammation and Sarcopenia/Frailty

Frailty | Sarcopenia | Aging

United States
Applied Biologics, LLC

Unknown

Safety & Efficacy FloGraft (Micronized Human Amnion Chorion Membrane)® in Adults With Pain Due to OA of the Knee (OA)

Osteoarthritis, Knee

United States
OncoImmune, Inc.

Completed

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) (SAC-COVID)

Coronavirus Disease 2019 (COVID-19)

United States
Akesobio Australia Pty Ltd

Completed

A Study of AK120 (IL-4Rα) in Healthy Subjects and Subjects With Moderate- to- Severe Atopic Dermatitis

Atopic Dermatitis

New Zealand, Australia
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...

Not yet recruiting

A Phase II Study of SSGJ-707 Combination Therapy in Advanced NSCLC Patients

First-line Advanced NSCLC Patients

China
Fresenius Kabi

Terminated

Fluid Resuscitation in Patients Suffering From Burns Injury

Burns

United Kingdom
Merck Sharp & Dohme LLC

Completed

Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001)

Cervical Cancer | Vulvar Cancer | Vaginal Cancer | Human Papillomavirus Infection | Genital Warts
Hoffmann-La Roche

Completed

A Study of Taspoglutide in Type 2 Diabetic Patients

Diabetes Mellitus Type 2

Germany
Hoffmann-La Roche

Completed

A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.

Diabetes Mellitus Type 2

Australia, Hong Kong, Romania, Mexico, United States, Bulgaria, Germany, Latvia, Lithuania, Guatemala
Shanghai Virogin Biotech Co., Ltd.

Recruiting

A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Biologic Effect of VG2025 in Patients With Solid Tumors

Advanced Malignant Solid Tumor

China
MediGene

Completed

EndoTAG-1 in Triple Receptor Negative Breast Cancer Patients

Breast Neoplasms

Belgium, France, Poland, India, Romania, Ukraine
Abbott Nutrition

Completed

Growth and Tolerance of Infants Fed Infant Formulas

Growth and Tolerance

United States, Puerto Rico
AM-Pharma

Withdrawn

A Study on the Tolerability and Early Efficacy of hLF1-11 in Patients With Bacteremia Due to S. Epidermidis (LIST)

Bacteremia | Staphylococcal Infections

Netherlands
Protalix

Withdrawn

Study to Evaluate the Safety and EffIcacy of PRX-102 on Gastrointestinal Symptoms in Naïve Fabry Disease

Fabry Disease
University of Padova

Terminated

Terlipressin + Albumin Versus Midodrine + Octreotide in the Treatment of Hepatorenal Syndrome

Cirrhosis | Hepatorenal Syndrome

Italy
University of Athens

Completed

Anakinra in Hidradenitis Suppurativa

Hidradenitis Suppurativa

Greece
London School of Hygiene and Tropical Medicine
Merck Sharp & Dohme LLC; Public Health England; University of Cambridge

Active, not recruiting

HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial (HPV)

Human Papillomavirus Vaccine

Gambia
Chinese PLA General Hospital

Unknown

Nab-paclitaxel Plus S-1 in Patients With Advanced Pancreatic Cancer (NAPSPAC)

Advanced Pancreatic Cancer

China
Shanghai Gebaide Biotechnology Co., Ltd.

Unknown

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

Non-small-cell Lung Cancer (NSCLC) Stage IV

China
Wuhan BravoVax Co., Ltd.
Novotech (Australia) Pty Limited; Shanghai BravoBio Co., Ltd.

Not yet recruiting

Phase I Clinical Trial of a Candidate HPV Vaccine

Human Papillomavirus Infection

Australia
Peking University
Centers for Disease Control and Prevention, China; Beijing Pinggu District... and other collaborators

Completed

Efficacy and Safety of Oral Lactobacillus Plantarum GUANKE (CGMCC NO.21720) in Enhancement of Antibody Level After SARS-CoV-2 Vaccination (Trial 2)

SARS-CoV-2

China
Dompé Farmaceutici S.p.A

Completed

Evaluation of Safety and Efficacy of rhNGF in Patients With Stage 2 and 3 Neurotrophic Keratitis. (REPARO)

Keratitis | Neurotrophic Keratitis | Corneal Ulcer

Germany, Italy, France, Poland, Spain, United Kingdom
Jesper Kjaergaard

Completed

GLP-1 Analogs for Neuroprotection After Cardiac Arrest (GLIP1)

Cardiac Arrest | Coma

Denmark
Fresenius Kabi

Completed

VolulyteTM in Cardiac Surgery

Heart; Dysfunction Postoperative, Cardiac Surgery

Canada
Stacy A. Kahn

Completed

Fecal Microbiota Transplant (FMT) in Pediatric Active Ulcerative Colitis and Pediatric Active Crohn's Colitis

Inflammatory Bowel Diseases | Crohn Disease | Ulcerative Colitis

United States
Celularity Incorporated
Celgene Corporation

Completed

A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

Crohn's Disease

United States
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Suspended

A Study of First-line JS001 and Nab-paclitaxel Versus Palcelbo and Nab-Paclitaxel in Participants With Advanced Recurrent or Metastatic TNBC

Triple Negative Breast Cancer

China
Eleven Biotherapeutics

Completed

Phase 1 Study for Safety and Tolerability of EBI-005 Topically Administered to Eyes of Healthy Adult Subjects (EBI-005-1)

Dry Eye

United States
Fundación Instituto de Estudios de Ciencias de...
Salamanca University Hospital; Instituto de Investigación Biomédica de Salamanca and other collaborators

Completed

Early Diagnosis of Kidney Damage Associated With Tobacco Use

Kidney Injury | Kidney Disease, Chronic | Tobacco Toxicity

Spain
Aerpio Therapeutics

Completed

Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD Effects in Male Volunteers

IBD

Canada
CNBG-Virogin Biotech (Shanghai) Ltd.

Recruiting

Clinical Study of VG161 in Subjects With Advanced Malignant Solid Tumors

Advanced Malignant Solid Tumor

China
US Department of Veterans Affairs

Completed

Vasoconstrictors as Alternatives to Albumin After Large-Volume Paracentesis (LVP) in Cirrhosis

Cirrhosis | Ascites

United States
Zensun Sci. & Tech. Co., Ltd.

Terminated

Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

Chronic Heart Failure

China
Zensun Sci. & Tech. Co., Ltd.

Terminated

Clinical Trial to Evaluate the Efficacy and Safety of Recombinant Human Neuregulin-1 for Subcutaneous Administration in Patients With Chronic Systolic Heart Failure

Chronic Heart Failure

China
Zensun Sci. & Tech. Co., Ltd.

Terminated

Study of Efficacy on Cardiac Remodeling of Recombinant Human Neuregulin-1 in Stable Chronic Systolic Heart Failure Patients

Chronic Systolic Heart Failure

China
Zensun Sci. & Tech. Co., Ltd.

Terminated

Study of Efficacy on NT-proBNP of Recombinant Human Neuregulin-1 in Chronic Heart Failure Patients

Chronic Heart Failure

China
Zensun Sci. & Tech. Co., Ltd.

Terminated

Study of the Survival of Recombinant Human Neuregulin-1β in Chronic Heart Failure (CHF) Patients

Chronic Heart Failure

China
NoNO Inc.

Withdrawn

Safety and Efficacy Study of a Single Dose of NA-1 in Patients Undergoing Endovascular Repair of Ruptured Aneurysms (ENACT-2)

Subarachnoid Hemorrhage | Ruptured Intracranial Aneurysm

Canada, United States
NoNO Inc.
Arbor Vita Corporation

Completed

Evaluating Neuroprotection in Aneurysm Coiling Therapy (ENACT)

Stroke

United States, Canada

Search clinical trials for: Placebo (human albumin 1%)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Thailand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations